BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25953442)

  • 1. Screening the molecular targets of ovarian cancer based on bioinformatics analysis.
    Du L; Qian X; Dai C; Wang L; Huang D; Wang S; Shen X
    Tumori; 2015; 101(4):384-9. PubMed ID: 25953442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of transcription profiling of solid pseudopapillary neoplasm of the pancreas.
    Zhang Y; Han X; Wu H; Zhou Y
    Mol Med Rep; 2017 Aug; 16(2):1635-1642. PubMed ID: 28627654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying endometriosis pathogenesis revealed by bioinformatics analysis of microarray data.
    Ping S; Ma C; Liu P; Yang L; Yang X; Wu Q; Zhao X; Gong B
    Arch Gynecol Obstet; 2016 Apr; 293(4):797-804. PubMed ID: 26354330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting of disease genes for gestational diabetes mellitus based on network and functional consistency.
    Zhang Q; He M; Wang J; Liu S; Cheng H; Cheng Y
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():91-6. PubMed ID: 25666344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile analysis of new candidate genes for the therapy of primary osteoporosis.
    Zhang Y; Wang N; Ma J; Chen XC; Li Z; Zhao W
    Eur Rev Med Pharmacol Sci; 2016; 20(3):433-40. PubMed ID: 26914116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
    Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
    Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of metastatic osteosarcoma: Differentially expressed genes, transcription factors and microRNAs.
    Heng L; Jia Z; Bai J; Zhang K; Zhu Y; Ma J; Zhang J; Duan H
    Mol Med Rep; 2017 May; 15(5):2829-2836. PubMed ID: 28260111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
    Zhang M; Luo SC
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated network analysis to explore the key genes regulated by parathyroid hormone receptor 1 in osteosarcoma.
    Guan D; Tian H
    World J Surg Oncol; 2017 Sep; 15(1):177. PubMed ID: 28934958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.